Hair and nail involvement in lupus erythematosus

Clinics in Dermatology
R M Trüeb

Abstract

Lupus erythematosus (LE) is a systemic autoimmune disorder associated with polyclonal B-cell activation, resulting in diverse patterns of autoantibody production and a heterogeneous clinical expression constituting a spectrum extending from limited cutaneous disease (cutaneous lupus LE) to a life-threatening systemic disease process (systemic LE). While the clinical characteristics of cutaneous LE are well defined in terms of morphology, and for the classification of systemic LE (SLE), clinical and laboratory criteria are available, recent advances in basic and clinical research have contributed to a better understanding of the cellular and molecular events that lead to LE. The importance of genetic susceptibility, environmental factors, and hormonal elements are well appreciated, although we as clinicians are faced with relatively late-term manifestations of the immunologic events that lead to the clinical manifestations of disease. Nevertheless, combining our knowledge of the clinical patterns of LE with the advances in our understanding of the underlying immunology, has led to the concept of "subsets" of disease, where a correlation between immune genetic markers, autoantibody profiles, distinctive cutaneous morphology, and ...Continue Reading

References

Dec 1, 1977·Southern Medical Journal·E Abell
Apr 1, 1992·The British Journal of Dermatology·C L WilsonR P Dawber
Jan 1, 1992·Dermatology : International Journal for Clinical and Investigative Dermatology·M S DoutreP Royer
Jun 1, 1992·Arthritis and Rheumatism·M Petri, J Allbritton
Feb 1, 1990·Journal of the American Academy of Dermatology·P LehmannG Plewig
Apr 1, 1988·The American Journal of Dermatopathology·V I Sulica, G F Kao
Aug 1, 1970·The British Journal of Dermatology·P W CopemanR R Kierland
Apr 1, 1974·The American Journal of the Medical Sciences·D Alarcon-Segovia, J A Cetina
May 1, 1970·Annals of the Rheumatic Diseases·W RedischC McEwen
May 1, 1984·Nihon rinsho. Japanese journal of clinical medicine·T Ofuji
Jan 1, 1980·The American Journal of Dermatopathology·R E Jordon
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
Apr 1, 1981·Journal of the American Academy of Dermatology·J N Gilliam, R D Sontheimer
Apr 1, 1995·Journal of Cutaneous Pathology·L C Sperling, G P Lupton
Apr 1, 1994·Journal of Cutaneous Pathology·S F Templeton, A R Solomon
Oct 1, 1993·Archives of Dermatology·R CaputoC Crosti
Jan 1, 1997·Journal of the American Academy of Dermatology·S KossardB Wilkinson
Aug 25, 1999·Journal of the American Academy of Dermatology·U WollinaP Oelzner
Feb 13, 2001·Journal of Cutaneous Pathology·A N Crowson, C Magro
Jul 5, 2001·Journal of Cutaneous Pathology·L C Sperling
Oct 12, 1964·JAMA : the Journal of the American Medical Association·E L DUBOIS, D L TUFFANELLI
Jun 1, 1996·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·D P Ascherman, P Katz

❮ Previous
Next ❯

Citations

Oct 9, 2013·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·R M Trüeb
Feb 24, 2009·Annales de dermatologie et de vénéréologie·B Cavelier-Balloy, P Assouly
Sep 11, 2016·International Journal of Dermatology·Keshavmurthy A AdyaAparna Palit
Dec 23, 2019·Clinics in Dermatology·Sonali NandaMariya Miteva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Related Papers

Dermatology : International Journal for Clinical and Investigative Dermatology
Stefan Trachsler, R M Trüeb
Journal of Cutaneous Pathology
L C Sperling
Journal of the American Academy of Dermatology
Elizabeth K RossJerry Shapiro
Dermatology : International Journal for Clinical and Investigative Dermatology
Sami Abdennader, Pascal Reygagne
© 2022 Meta ULC. All rights reserved